Information for "Doxorubicin decreases medicine level of resistance involving SCLC cells by simply suppressing the actual inflamation related microenvironment as well as the STAT3VEGF pathway"
From EECH Central
Basic information
| Display title | Doxorubicin decreases medicine level of resistance involving SCLC cells by simply suppressing the actual inflamation related microenvironment as well as the STAT3VEGF pathway |
| Default sort key | Doxorubicin decreases medicine level of resistance involving SCLC cells by simply suppressing the actual inflamation related microenvironment as well as the STAT3VEGF pathway |
| Page length (in bytes) | 3,687 |
| Page ID | 20874 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Bomberliquor1 (Talk | contribs) |
| Date of page creation | 08:10, 31 March 2023 |
| Latest editor | Bomberliquor1 (Talk | contribs) |
| Date of latest edit | 08:10, 31 March 2023 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
